Piperine Nanoparticles Significantly Improved Fragile X–Associated Tremor/Ataxia Syndrome via Mitigating RNA and Repeat‐Associated Non‐AUG Toxicities
Small Science · 2026-11 · 6 (11)
DOI: 10.1002/smsc.70443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Science, online erschienen am 16.11.2026. Verfasst von Jiahao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening School of Pharmacy Faculty of Medicine The Chinese University of Hong Kong Shatin H…. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fragile X–associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder driven by fragile X messenger ribonucleoprotein 1 ( FMR1 ) premutation CGG repeats on the X chromosome, causing RNA and repeat‐associated non‐AUG (RAN) toxicities. Although piperine demonstrated preliminary mitigation of RNA toxicity, its poor aqueous solubility restricted further development. The current study evaluated piperine nanoparticles (PIP NPs) with enhanced solubility for FXTAS management. Briefly, PIP NPs were prepared using flash nanoprecipitation followed by assessing their impact on both CGG repeat Drosophila and mouse models. PIP NPs could significantly ameliorate the climbing deficits, protect against early‐stage mortality (100 μM) and preserve retinal integrity in CGG repeat Drosophila , and rescue motor coordination and abnormal learning conditioning in CGG repeat mice, while reducing toxic FMR1 mRNA, restoring Drosophila fragile X messenger ribonucleoprotein 1 (dFmr1) or fragile X messenger ribonucleoprotein (FMRP) expression, suppressing FMRpolyG‐GFP production in Drosophila , and mitigating ubiquitin‐positive intranuclear inclusions. Based on the findings, molecular docking analyses were adopted to provide a computational structural rationale for the proposed interactions between piperine and DExH‐box helicase 9 (DHX9)/death‐associated protein 5 (DAP5)/heat shock protein 70 (Hsp70). The serial in vitro, in vivo, and in silico investigations consistently demonstrated PIP NPs as a promising therapeutic candidate for FXTAS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening School of Pharmacy Faculty of Medicine The Chinese University of Hong Kong Shatin Hong Kong SAR.
- School of Life Sciences Faculty of Science The Chinese University of Hong Kong Shatin Hong Kong SAR.
- Gerald Choa Neuroscience Institute The Chinese University of Hong Kong Shatin Hong Kong SAR.
ORCID-Profile: Mingxi Ou, Zhefan Stephen Chen, Ho Yin Edwin Chan, Sharon Shui Yee Leung, Zhong Zuo
Zitieren
APA
Li, J., Ou, M., Chen, Z. S., Ban, W., Chan, H. Y. E., Leung, S. S. Y., & Zuo, Z. (2026). Piperine Nanoparticles Significantly Improved Fragile X–Associated Tremor/Ataxia Syndrome via Mitigating RNA and Repeat‐Associated Non‐AUG Toxicities. Small Science, 6(11). https://doi.org/10.1002/smsc.70443
Vancouver
Li J, Ou M, Chen ZS, Ban W, Chan HYE, Leung SSY, et al. Piperine Nanoparticles Significantly Improved Fragile X–Associated Tremor/Ataxia Syndrome via Mitigating RNA and Repeat‐Associated Non‐AUG Toxicities. Small Science. 2026;6(11). doi:10.1002/smsc.70443
BibTeX
@article{Li2026,
author = {Li, Jiahao and Ou, Mingxi and Chen, Zhefan Stephen and Ban, Weikang and Chan, Ho Yin Edwin and Leung, Sharon Shui Yee and Zuo, Zhong},
title = {Piperine Nanoparticles Significantly Improved Fragile X–Associated Tremor/Ataxia Syndrome via Mitigating RNA and Repeat‐Associated Non‐AUG Toxicities},
journal = {Small Science},
year = {2026},
volume = {6},
number = {11},
doi = {10.1002/smsc.70443}
}
EUVIMED